# Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

> **NCT01121835** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 934 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** INSULIN GLARGINE
- **DRUG:** INSULIN GLULISINE
- **DRUG:** PREMIXED INSULIN

## Key facts

- **NCT ID:** NCT01121835
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 934 (ACTUAL)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121835, "Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01121835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*